Growth Metrics

Vanda Pharmaceuticals (VNDA) Cash & Equivalents Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -51.77%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 24.73%
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -28.55%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 13.33%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -16.07%
7 Evaxion A 62.56 Bn 62.54 Bn - 21.66%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -8.88%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 36.53%
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn -46.57%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -46.57%
Dec 31, 2025 -14.35%
Sep 30, 2025 12.33%
Jun 30, 2025 11.62%
Mar 31, 2025 18.65%
Dec 31, 2024 25.25%
Sep 30, 2024 25.76%
Jun 30, 2024 21.61%
Mar 31, 2024 20.16%
Dec 31, 2023 30.56%
Sep 30, 2023 47.60%
Jun 30, 2023 16.33%
Mar 31, 2023 76.01%
Dec 31, 2022 44.16%
Sep 30, 2022 8.00%
Jun 30, 2022 7.75%
Mar 31, 2022 24.86%
Dec 31, 2021 -5.14%
Sep 30, 2021 -5.97%
Jun 30, 2021 -2.04%
Mar 31, 2021 -22.56%
Dec 31, 2020 21.98%
Sep 30, 2020 36.13%
Jun 30, 2020 88.49%
Mar 31, 2020 47.81%
Dec 31, 2019 -23.56%
Sep 30, 2019 6.17%
Jun 30, 2019 26.13%
Mar 31, 2019 -3.90%
Dec 31, 2018 6.26%
Sep 30, 2018 9.11%
Jun 30, 2018 8.00%
Mar 31, 2018 67.90%
Dec 31, 2017 -17.96%
Sep 30, 2017 13.84%
Jun 30, 2017 -5.74%
Mar 31, 2017 -22.53%
Dec 31, 2016 15.93%
Sep 30, 2016 -38.69%
Jun 30, 2016 -39.29%
Mar 31, 2016 -29.37%
Dec 31, 2015 -16.95%
Sep 30, 2015 -23.50%
Jun 30, 2015 -19.99%
Mar 31, 2015 -32.80%
Dec 31, 2014 -11.52%
Sep 30, 2014 -36.69%
Jun 30, 2014 -30.39%
Mar 31, 2014 -6.26%
Dec 31, 2013 15.02%
Sep 30, 2013 11.53%
Jun 30, 2013 -10.73%
Dec 31, 2012 -24.38%